These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38524785)

  • 21. Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK).
    Jolliffe DA; Faustini SE; Holt H; Perdek N; Maltby S; Talaei M; Greenig M; Vivaldi G; Tydeman F; Symons J; Davies GA; Lyons RA; Griffiths CJ; Kee F; Sheikh A; Shaheen SO; Richter AG; Martineau AR
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sociodemographic differences in Covid-19 vaccine uptake in Denmark: a nationwide register-based cohort study.
    Gram MA; Moustsen-Helms IR; Valentiner-Branth P; Emborg HD
    BMC Public Health; 2023 Feb; 23(1):391. PubMed ID: 36829138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
    Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
    Elife; 2023 Jan; 12():. PubMed ID: 36692910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study.
    Bouillon K; Baricault B; Botton J; Jabagi MJ; Bertrand M; Semenzato L; Le Vu S; Drouin J; Dray-Spira R; Weill A; Zureik M
    BMJ Med; 2022; 1(1):e000104. PubMed ID: 36936561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
    Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
    Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Oda Y; Kumagai Y; Kanai M; Iwama Y; Okura I; Minamida T; Yagi Y; Kurosawa T; Greener B; Zhang Y; Walson JL
    Lancet Infect Dis; 2024 Apr; 24(4):351-360. PubMed ID: 38141632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 vaccination among young people who use drugs in Vancouver, Canada.
    McAdam E; Hayashi K; Barker B; Reddon H; Choi J; Kerr T; DeBeck K
    Vaccine; 2024 Feb; 42(4):864-870. PubMed ID: 38225183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
    Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
    JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 Vaccination Rates and Predictors of Uptake Among Adults With Coronary Heart Disease: Insight From the 2022 National Health Interview Survey.
    Ezeamii VC; Ofochukwu VC; Iheagwara C; Asibu T; Ayo-Farai O; Gebeyehu YH; Kaglo EO; Odoeke MC; Adeyemi OM; Shittu HO; Okobi OE
    Cureus; 2024 Jan; 16(1):e52480. PubMed ID: 38371067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chappell KJ; Mordant FL; Li Z; Wijesundara DK; Ellenberg P; Lackenby JA; Cheung STM; Modhiran N; Avumegah MS; Henderson CL; Hoger K; Griffin P; Bennet J; Hensen L; Zhang W; Nguyen THO; Marrero-Hernandez S; Selva KJ; Chung AW; Tran MH; Tapley P; Barnes J; Reading PC; Nicholson S; Corby S; Holgate T; Wines BD; Hogarth PM; Kedzierska K; Purcell DFJ; Ranasinghe C; Subbarao K; Watterson D; Young PR; Munro TP
    Lancet Infect Dis; 2021 Oct; 21(10):1383-1394. PubMed ID: 33887208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to increase COVID-19 vaccine uptake among children? determinants associated with vaccine compliance.
    Hoshen M; Shkalim Zemer V; Ashkenazi S; Grossman Z; Gerstein M; Yosef N; Cohen M; Cohen HA
    Front Pediatr; 2022; 10():1038308. PubMed ID: 36714648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study.
    Lundberg-Morris L; Leach S; Xu Y; Martikainen J; Santosa A; Gisslén M; Li H; Nyberg F; Bygdell M
    BMJ; 2023 Nov; 383():e076990. PubMed ID: 37993131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose.
    Morrison K; Cullen L; James AB; Chua V; Sullivan C; Robertson C; Carruthers J; Wood R; Jeffrey K; MacDonald C; Shah SA; Rudan I; Simpson CR; McCowan C; Vittal Katikireddi S; Grange Z; Ritchie L; Sheikh A
    Vaccine; 2023 Sep; 41(40):5863-5876. PubMed ID: 37598025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study.
    Seibold MA; Moore CM; Everman JL; Williams BJM; Nolin JD; Fairbanks-Mahnke A; Plender EG; Patel BB; Arbes SJ; Bacharier LB; Bendixsen CG; Calatroni A; Camargo CA; Dupont WD; Furuta GT; Gebretsadik T; Gruchalla RS; Gupta RS; Khurana Hershey GK; Murrison LB; Jackson DJ; Johnson CC; Kattan M; Liu AH; Lussier SJ; O'Connor GT; Rivera-Spoljaric K; Phipatanakul W; Rothenberg ME; Seroogy CM; Teach SJ; Zoratti EM; Togias A; Fulkerson PC; Hartert TV;
    J Allergy Clin Immunol; 2022 Aug; 150(2):302-311. PubMed ID: 35660376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Priority Settings at the Start of COVID-19 Mass Vaccination on Subsequent Vaccine Uptake in Japan: One-Year Prospective Cohort Study.
    Hori D; Takahashi T; Ozaki A; Tabuchi T
    JMIR Public Health Surveill; 2023 Jul; 9():e42143. PubMed ID: 37235691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Before Coronavirus Disease 2019 Vaccination Among Children 0-4 Years and Their Household Members in the SEARCh Study.
    Garcia Quesada M; Hetrich MK; Zeger S; Sharma J; Na YB; Veguilla V; Karron RA; Dawood FS; Knoll MD;
    Open Forum Infect Dis; 2022 Oct; 9(10):ofac507. PubMed ID: 36324323
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.